Hematologic Malignancies With RUNX1::ZFPM2 Translocation: A Case Report and Literature Review
eJHaem · 2026-10 · 7 (5)
DOI: 10.1002/jha2.70395 ↗Abstract
ABSTRACT RUNX1 rearrangements are recurrent in myeloid neoplasms, but rare fusion partners remain poorly characterized. We report the first acute myeloid leukemia (AML) with a RUNX1::ZFPM2 fusion generated by t(8;21)(q23;q22). A 72‐year‐old woman presented with acute myelomonocytic leukemia carrying concomitant IDH2 and NRAS mutations. Azacitidine–venetoclax induced transient remission with a marked decrease in the fusion transcript. However, persistent cytopenias, molecular relapse, and treatment resistance led to death 1 year after diagnosis. This case expands the spectrum of RUNX1 ‐rearranged AML and suggests a biological behavior distinct from classical RUNX1::RUNX1T1 ‐positive AML. Trial Registration The authors have confirmed clinical trial registration is not needed for this submission.
EUVIMED